One out of the three major indices are trading up today with the

Dow Jones Industrial Average

(

^DJI

) trading down 8 points (0.0%) at 17,223 as of Tuesday, Oct. 20, 2015, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,678 issues advancing vs. 1,268 declining with 204 unchanged.

The Health Services industry currently sits down 1.3% versus the S&P 500, which is up 1657.1%. On the negative front, top decliners within the industry include

Opko Health

(

OPK

), down 5.9%,

Varian Medical Systems

(

VAR

), down 4.4%,

Aetna

(

AET

), down 2.3%,

HCA Holdings

(

HCA

), down 1.6% and

Stryker Corporation

(

SYK

), down 1.3%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3.

Envision Healthcare Holdings

(

EVHC

) is one of the companies pushing the Health Services industry higher today. As of noon trading, Envision Healthcare Holdings is up $1.00 (2.8%) to $37.00 on heavy volume. Thus far, 1.7 million shares of Envision Healthcare Holdings exchanged hands as compared to its average daily volume of 1.4 million shares. The stock has ranged in price between $36.59-$38.64 after having opened the day at $36.70 as compared to the previous trading day's close of $36.00.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Envision Healthcare Holdings, Inc. provides physician-led, outsourced medical services to consumers, hospitals, healthcare systems, health plans, and government entities in the United States. Envision Healthcare Holdings has a market cap of $6.6 billion and is part of the health care sector. Shares are up 3.8% year-to-date as of the close of trading on Monday. Currently there are 12 analysts who rate Envision Healthcare Holdings a buy, no analysts rate it a sell, and 2 rate it a hold.

TheStreet Ratings rates

Envision Healthcare Holdings

as a

hold

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth and compelling growth in net income. However, as a counter to these strengths, we also find weaknesses including poor profit margins and generally higher debt management risk. Get the full

Envision Healthcare Holdings Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

2. As of noon trading,

Mednax

(

MD

) is up $1.65 (2.0%) to $82.02 on average volume. Thus far, 365,973 shares of Mednax exchanged hands as compared to its average daily volume of 719,600 shares. The stock has ranged in price between $80.59-$82.36 after having opened the day at $80.86 as compared to the previous trading day's close of $80.37.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

MEDNAX, Inc., together with its subsidiaries, provides neonatal, anesthesia, maternal-fetal, and other pediatric subspecialties physician services in the United States and Puerto Rico. Mednax has a market cap of $7.5 billion and is part of the health care sector. Shares are up 21.6% year-to-date as of the close of trading on Monday. Currently there are 11 analysts who rate Mednax a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates

Mednax

as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, solid stock price performance and growth in earnings per share. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full

Mednax Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

1. As of noon trading,

CVS Health

(

CVS

) is up $0.79 (0.8%) to $103.95 on average volume. Thus far, 1.9 million shares of CVS Health exchanged hands as compared to its average daily volume of 4.9 million shares. The stock has ranged in price between $103.17-$104.40 after having opened the day at $103.24 as compared to the previous trading day's close of $103.16.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services in the United States. The company operates through Pharmacy Services and Retail Pharmacy segments. CVS Health has a market cap of $115.2 billion and is part of the health care sector. Shares are up 7.5% year-to-date as of the close of trading on Monday. Currently there are 15 analysts who rate CVS Health a buy, no analysts rate it a sell, and 2 rate it a hold.

TheStreet Ratings rates

CVS Health

as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, increase in net income, good cash flow from operations and solid stock price performance. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full

CVS Health Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health services industry could consider

ProShares Ultra Short Health Care

(

RXD

).